Dr. Ebert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Avenue, Dana 1610A
Dana-Farber Cancer Institute
Boston, MA 02115Phone+1 617-632-1902- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2005
- Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2001
- Harvard Medical SchoolClass of 1999
Certifications & Licensure
- MA State Medical License 2004 - 2025
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- 1 citationsMezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, Daniela V Wenge, Florian Perner, Cynthia Martucci, Jill A Henrich, Kelly Klega, Radosław P Nowak, Katherine A Dono...> ;Blood. 2024 Apr 11
- Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, La...> ;EMBO Molecular Medicine. 2024 Mar 1
- Clonal Hematopoiesis of Indeterminate Potential With Loss ofEnhances Risk for Atrial Fibrillation ThroughInflammasome Activation.Lin, A., Bapat, A., Xiao, L., Niroula, A., Ye, J., Wong, W., Agrawal, M., Farady, C., Boettcher, A., Hergott, C., McConkey, M., Flores-Bringas, P., Shkolnik, V., Bick,...> ;Circulation. 2024 Feb 15
- Join now to see all
Journal Articles
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorRobert Sidlow, Amy E Lin, David P Steensma, Benjamin L Ebert, JAMA Cardiology
- Defining the Human C2H2 Zinc Finger Degrome Targeted by Thalidomide Analogs Through CRBNBenjamin Ebert, MD, Science Magazine
- CrbnI391V Is Sufficient to Confer in Vivo Sensitivity to Thalidomide and Its Derivatives in MiceBenjamin L Ebert, Emma C Fink, Blood
- Join now to see all
Abstracts/Posters
- High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center DisasterBenjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Talazoparib Treatment Preferentially Depletes Cohesin-Mutant Clones in New In Vivo Models of Cohesin-Mutant Myeloid DiseasesBenjamin Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Functional Characterization of E3 Ligases and Their Regulators: Therapeutic Implications for Development of New Proteolysis-Targeting Chimeric Degraders of OncoproteinsBenjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- When You Least Expect It: Clonal Hematopoiesis as an Incidental FindingASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- Friday Scientific Workshop on Myeloid Development61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Optimizing Clinical Outcomes in Blood Cancers Through Groundbreaking Translational Research61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Authored Content
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorMay 2020
Press Mentions
- 5 from HMS Elected to American Academy of Arts and SciencesMay 4th, 2023
- Novel Clinical Tool for Clonal Hematopoiesis Identifies High Risk for Clonal Hematopoiesis PatientsApril 28th, 2023
- Clonal Hematopoiesis Clinical Tool Identifies Those at Risk for Blood CancerDecember 13th, 2022
- Join now to see all
Grant Support
- Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2010–2011
- Novel Treatment Strategies For Sickle Cell DiseaseNational Center For Research Resources2010–2011
- Identification Of Functional Tumor-Stromal Interactions In The Bone MarrowNational Cancer Institute2009–2010
- Functional Dissection Of Erythroid DifferentiationNational Heart, Lung, And Blood Institute2008–2009
- Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2008
- Functional Dissection Of Erythroid DifferentiationNational Heart, Lung, And Blood Institute2005–2007
- High Throughput Screen For Regulators Of Globin Gene Ex*National Human Genome Research Institute2006
- High Throughput Screen For Regulators Of GlobinNational Human Genome Research Institute2005
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: